Enzymotec raises $63.5 million in Nasdaq IPO

– The lipid-based products developer held the IPO at $14 per share, below its target of $16-18, but the share price rose 30% on Friday. – – Enzymotec Ltd. (Nasdaq: ENZY) has raised a net More...

Enzymotec publishes Nasdaq IPO prospectus

– Enzymotec, which has developed a proprietary method for processing fatty acids, is seeking to raise $75 million. – – / By Gali Weinreb /  Nutritional supplements company Enzymotec More...